Dolby Laboratories Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Dolby Laboratories de 17.4% y 5.3% respectivamente, mientras que el BPA crecerá en un 17.3% al año.
Información clave
17.4%
Tasa de crecimiento de los beneficios
17.3%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Software | 15.7% |
| Tasa de crecimiento de los ingresos | 5.3% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 22 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist
Apr 16
Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate
Mar 17Dolby Laboratories Sees Flat Revenue Ahead (Downgrade)
Mar 01Dolby Laboratories' (NYSE:DLB) Earnings Offer More Than Meets The Eye
Feb 09What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
Jan 31With Dolby Laboratories, Inc. (NYSE:DLB) It Looks Like You'll Get What You Pay For
Jan 15The Return Trends At Dolby Laboratories (NYSE:DLB) Look Promising
Dec 28Dolby Laboratories: On A Positive Hold As Shareholder Rewards Continue
Dec 06A Look At The Fair Value Of Dolby Laboratories, Inc. (NYSE:DLB)
Nov 18At US$81.66, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?
Oct 11Dolby Laboratories: High P/E Is Not Justified, A Hold For Now
Sep 13The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing
Aug 03What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
Jul 12Dolby Laboratories Sees Return To Growth Ahead
Jun 22Returns On Capital At Dolby Laboratories (NYSE:DLB) Paint A Concerning Picture
May 04A Look At The Intrinsic Value Of Dolby Laboratories, Inc. (NYSE:DLB)
Apr 14Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?
Mar 29Dolby Laboratories goes ex-dividend on Monday
Feb 10Dolby Laboratories FQ1 2023 Earnings Preview
Feb 01Dolby Laboratories (NYSE:DLB) Could Be At Risk Of Shrinking As A Company
Jan 24Dolby: A 2023 Update, And Still A 'Hold'
Jan 11An Intrinsic Calculation For Dolby Laboratories, Inc. (NYSE:DLB) Suggests It's 25% Undervalued
Jan 09Is Dolby Laboratories, Inc. (NYSE:DLB) Potentially Undervalued?
Dec 25Dolby Laboratories' (NYSE:DLB) Dividend Will Be Increased To $0.27
Nov 21Dolby: Great Moat But Not Such A Great Investment Idea
Oct 29Is There An Opportunity With Dolby Laboratories, Inc.'s (NYSE:DLB) 38% Undervaluation?
Oct 05Dolby Laboratories Seeks Broader Growth As Macro Conditions Weigh
Sep 28At US$72.98, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?
Sep 20Be Wary Of Dolby Laboratories (NYSE:DLB) And Its Returns On Capital
Aug 20Dolby Laboratories goes ex-dividend tomorrow
Aug 19Dolby Laboratories Non-GAAP EPS of $0.68 beats by $0.09, revenue of $289.59M misses by $4.44M
Aug 09Dolby: Is Low-Yield Growth Worth It In This Market?
Jul 17An Intrinsic Calculation For Dolby Laboratories, Inc. (NYSE:DLB) Suggests It's 41% Undervalued
Jul 03Is It Time To Consider Buying Dolby Laboratories, Inc. (NYSE:DLB)?
Jun 17Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 9/30/2026 | 1,499 | 309 | 464 | 536 | 2 |
| 9/30/2025 | 1,361 | 273 | 418 | 483 | 4 |
| 9/30/2024 | 1,298 | 230 | 364 | 426 | 4 |
| 12/29/2023 | 1,280 | 188 | 290 | 319 | N/A |
| 9/29/2023 | 1,300 | 201 | 337 | 367 | N/A |
| 6/30/2023 | 1,287 | 219 | 301 | 333 | N/A |
| 3/31/2023 | 1,279 | 242 | 348 | 385 | N/A |
| 12/30/2022 | 1,237 | 183 | 303 | 343 | N/A |
| 9/30/2022 | 1,254 | 184 | 259 | 319 | N/A |
| 7/1/2022 | 1,261 | 201 | 316 | 377 | N/A |
| 4/1/2022 | 1,258 | 216 | 314 | 377 | N/A |
| 12/31/2021 | 1,243 | 255 | 332 | 397 | N/A |
| 9/24/2021 | 1,281 | 310 | 393 | 448 | N/A |
| 6/25/2021 | 1,267 | 293 | 398 | 451 | N/A |
| 3/26/2021 | 1,228 | 306 | 359 | 413 | N/A |
| 12/25/2020 | 1,260 | 318 | 334 | 395 | N/A |
| 9/25/2020 | 1,162 | 231 | 275 | 344 | N/A |
| 6/26/2020 | 1,189 | 248 | 287 | 362 | N/A |
| 3/27/2020 | 1,245 | 221 | 234 | 319 | N/A |
| 12/27/2019 | 1,231 | 206 | 195 | 302 | N/A |
| 9/27/2019 | 1,242 | 255 | 214 | 328 | N/A |
| 6/28/2019 | 1,183 | 238 | 194 | 309 | N/A |
| 3/29/2019 | 1,096 | 201 | 253 | 360 | N/A |
| 12/28/2018 | 1,057 | 193 | 307 | 392 | N/A |
| 9/28/2018 | 1,055 | 42 | 267 | 352 | N/A |
| 6/29/2018 | 1,056 | 37 | 236 | 321 | N/A |
| 3/30/2018 | 1,147 | 110 | 216 | 317 | N/A |
| 12/29/2017 | 1,115 | 95 | 211 | 324 | N/A |
| 9/29/2017 | 1,080 | 206 | N/A | 378 | N/A |
| 6/30/2017 | 1,072 | 204 | N/A | 370 | N/A |
| 3/31/2017 | 1,044 | 192 | N/A | 359 | N/A |
| 12/30/2016 | 1,051 | 208 | N/A | 360 | N/A |
| 9/30/2016 | 1,026 | 186 | N/A | 360 | N/A |
| 7/1/2016 | 1,025 | 208 | N/A | 367 | N/A |
| 4/1/2016 | 980 | 180 | N/A | 288 | N/A |
| 1/1/2016 | 977 | 171 | N/A | 373 | N/A |
| 9/25/2015 | 971 | 181 | N/A | 309 | N/A |
| 6/26/2015 | 965 | 181 | N/A | 316 | N/A |
| 3/27/2015 | 956 | 185 | N/A | 360 | N/A |
| 12/26/2014 | 963 | 203 | N/A | 288 | N/A |
| 9/26/2014 | 960 | 206 | N/A | 362 | N/A |
| 6/27/2014 | 950 | 206 | N/A | 339 | N/A |
| 3/28/2014 | 934 | 196 | N/A | 332 | N/A |
| 12/27/2013 | 904 | 182 | N/A | 286 | N/A |
| 9/27/2013 | 910 | 189 | N/A | 277 | N/A |
| 6/28/2013 | 919 | 195 | N/A | 286 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (17.4% al año) de DLB es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Se prevé que los beneficios (17.4% al año) de DLB crezcan más rápidamente que el mercado US (14.7% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de DLB crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (5.3% al año) de DLB crezcan más despacio que el mercado de US (8.1% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 5.3% al año) de DLB crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de DLB se prevé que sea elevada dentro de 3 años.